Monday, 23 September 2019

Chinese agritech facility to employ world's largest corn husker

13 September 2012 | News | By BioSpectrum Bureau

Origin Agritech Inaugurates Xinjiang Corn Seed Processing Center

Origin Agritech subsidiary, Xinjiang Origin, inaugurates corn seed processing center in China

Origin Agritech subsidiary, Xinjiang Origin, inaugurates corn seed processing center in China

Singapore: Xinjiang Origin, a subsidiary of Origin Agritech, held an opening ceremony for its regional corn seed processing facility at Bole, Xinjiang, China. Origin Agritech is a technology-focused supplier of hybrid and genetically modified crop seeds in China. The state-of-the-art facility will mainly produce, process, package, and sell high-quality hybrid corn seeds to the domestic Chinese market. The processing facility will employ an advanced corn husker system, which is one of the largest corn huskers in the world.

The joint venture will increase Xinjiang Origin's total seed processing capacity and expand marketing channels to distribute Origin's hybrid products to the northwest region in China.

Established in June, 2011, Xinjiang Origin is a joint venture seed company between Origin and Xinjiang Jinbo Seed. Jinbo is a prominent local seed company affiliated with the Fifth Agricultural Construction Division of the Xinjiang Production and Construction Corps. Origin holds a 51 percent ownership stake and retains the exclusive joint venture partnership with Jinbo in Xinjiang.

Dr Gengchen Han, chairman and CEO, and Dr James Chen, CFO, Origin, hosted the ribbon-cutting ceremony. Senior officials from the Ministry of Agriculture as well as the Fifth Agricultural Construction Division of Xinjiang Production and Construction Corps attended the event as honorary guests.

Dr Gengchen Han, chairman and CEO, Origin, commented that, "Xinjiang Origin not only addresses the increasing demand for our superior hybrid seed products, but diversifies our cost structure and production base, and expands our sales channels into a new market. With our new management team, leaner corporate structure and the new facility, we are now poised for the next stage of growth."

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls